Ali Ataya, MD.

Program Director of Pulmonary and Pulmonary Hypertension
University of Florida Health

Poster(s):

• (1189) Low-Dose Versus Standard-Dose Alteplase for the Treatment of High-Risk Pulmonary Embolism
  Tuesday, January 23, 2024

  10:00 AM – 11:00 AM MT